Therefore, it is not surprising that targeting some molecules that can control the activity of immune cells, such as interleukin (IL)-1 (14) and tumor necrosis factor (TNF) α (15), has been reported to be effective in diminishing diabetes progression. Here, TNF is linked to diabetes mellitus.